Genomics Essentials in Hematologic Malignancies
Genomic profiling is widely recognized as a key way to develop strategies for treating hematologic (and other) cancers. Are you looking for more information on genomic tests available and how to apply the results to clinical care? Are you confident with educating patients on the meaning of tests, testing results, and their implication on treatment decision? Participate in GENOM, a free education program created in partnership by ASH, Leukemia and Lymphoma Society, and The France Foundation.
The GENOM program offers interactive online learning modules for CME credit designed to help clinicians identify genomic principles, applications, technologies, and terminology relating to biomarker development. GENOM features two modules:
- Foundations, an interactive series exploring the basics of genomics in the context of hematologic malignancies.
- Applications, a series of disease-specific case-based modules exploring relevant biomarkers, available therapies, patient communication strategies and emerging research.
Who Should Participate?
This activity is intended for hematologists, hematologists/oncologists, medical oncologists, nurses, and physician assistants and nurse practitioners who are caring for patients with blood cancers.
- Jennifer Brown, MD, PhD (Steering Committee Chair), Dana-Farber Cancer Institute, Harvard Medical School
- Anjali Advani, MD, Cleveland Clinic Lerner College of Medicine
- Rafael Fonseca, MD, Mayo Clinic Comprehensive Cancer Center
- Patricia Friend, PhD, APRN-CNS, AOCNS, AGN-BC, Loyola University Chicago
- Neha Mehta-Shah, MD, MSCI, Washington University in St. Louis School of Medicine
- Alice Mims, MD, The Ohio State University Comprehensive Cancer Center
- Charles Mullighan, MBBS (Hons), MSc, MD, St. Jude Children’s Research Hospital
This activity is provided by the American Society of Hematology, the Leukemia and Lymphoma Society, and The France Foundation.